Derivatives as 5HT1A receptor ligands -: Past and present

被引:82
作者
Caliendo, G [1 ]
Santagada, V [1 ]
Perissutti, E [1 ]
Fiorino, F [1 ]
机构
[1] Dipartimento Chim Farmaceut & Tossicol, I-80131 Naples, Italy
关键词
D O I
10.2174/0929867054367220
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serotonin is a neuromediator, well-know for its implication in mood regulation, anxiety, depression and, insomnia as well as in normal human function such as sleep, sexual activity and appetite. In this way, serotonin (5-hydroxytryptamine, 5-HT) is one of the most attractive targets for medicinal chemists and pharmaceutical companies. Among 5-HTRs, the 5-HT1A subtype is the best studied, and it is generally accepted that it is involved in psychiatric disorders such as anxiety and depression. Several structurally different compounds are known to bind 5-HT1A receptor sites such as aminotetralins, ergolines, arylpiperazines, indolylalkylamines, aporphines and aryloxyalkyl-amines.
引用
收藏
页码:1721 / 1753
页数:33
相关论文
共 166 条
  • [1] Synthesis and SAR of adatanserin:: Novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents
    Abou-Gharbia, MA
    Childers, WE
    Fletcher, H
    McGaughey, G
    Patel, U
    Webb, MB
    Yardley, J
    Andree, T
    Boast, C
    Kucharik, RJ
    Marquis, K
    Morris, H
    Scerni, R
    Moyer, JA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) : 5077 - 5094
  • [2] POLYCYCLIC ARYLPIPERAZINYL AND HETEROARYLPIPERAZINYL IMIDES AS 5-HT1A RECEPTOR LIGANDS AND POTENTIAL ANXIOLYTIC AGENTS - SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES
    ABOUGHARBIA, M
    PATEL, UR
    WEBB, MB
    MOYER, JA
    ANDREE, TH
    MUTH, EA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (07) : 1382 - 1392
  • [3] SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIP OF SUBSTITUTED TETRAHYDRO AND HEXAHYDRO-1,2-BENZISOTHIAZOL-3-ONE 1,1-DIOXIDES AND THIADIAZINONES - POTENTIAL ANXIOLYTIC AGENTS
    ABOUGHARBIA, M
    MOYER, JA
    PATEL, U
    WEBB, M
    SCHIEHSER, G
    ANDREE, T
    HASKINS, JT
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (05) : 1024 - 1033
  • [4] PRECLINICAL PHARMACOLOGY OF FG5893 - A POTENTIAL ANXIOLYTIC DRUG WITH HIGH-AFFINITY FOR BOTH 5-HT1A AND 5-HT2A RECEPTORS
    ALBINSSON, A
    BJORK, A
    SVARTENGREN, J
    KLINT, T
    ANDERSSON, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 261 (03) : 285 - 294
  • [5] ANDRZEJ J, 2002, BIOORGAN MED CHEM, V10, P3817
  • [6] [Anonymous], PSYCHOPHARMACOLOGY 4
  • [7] [Anonymous], CURRENT DRUGS SEROTO
  • [8] 8-HYDROXY-2-(DI-NORMAL-PROPYLAMINO)TETRALIN, A NEW CENTRALLY ACTING 5-HYDROXYTRYPTAMINE RECEPTOR AGONIST
    ARVIDSSON, LE
    HACKSELL, U
    NILSSON, JLG
    HJORTH, S
    CARLSSON, A
    LINDBERG, P
    SANCHEZ, D
    WIKSTROM, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (08) : 921 - 923
  • [9] (+)-CIS-8-HYDROXY-1-METHYL-2-(DI-NORMAL-PROPYLAMINO)TETRALIN - A POTENT AND HIGHLY STEREOSELECTIVE 5-HYDROXYTRYPTAMINE RECEPTOR AGONIST
    ARVIDSSON, LE
    JOHANSSON, AM
    HACKSELL, U
    NILSSON, JLG
    SVENSSON, K
    HJORTH, S
    MAGNUSSON, T
    CARLSSON, A
    ANDERSSON, B
    WIKSTROM, H
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (11) : 2105 - 2109
  • [10] BAMBERGER E, 1888, BER, V21, P1112